Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Seizure. 2017 Oct 16;52:199–204. doi: 10.1016/j.seizure.2017.10.006

Table 1.

Demographics

Sex – Female (%) 50%
Age (years): Median (IQR; min/max) 58 (29; 6/96)
Weight (kg) Median (IQR; min/max) 75 (27; 22/159)
PHT vs. FOS used for loading dose 41(8%)/453(92%)
Loading dose (mg)
 Median (IQR; min/max) 1378 (629; 500/2614)
 Mean 1356
Loading dose (mg/kg)
 Median (IQR; min/max) 19 (5; 4/31)
 Mean 18
Maintenance dose (MD), Mean (mg) 112
Weight adjusted maintenance dose, Mean (mg/kg) 1.5
Additional Loading dose, Mean (mg) 931
Weight adjusted additional Loading dose, Mean (mg/kg) 11
Timing in hours of the serum lab draw following a loading dose, Mean (Min/Max)
 LD Only 7 (2/24)
 LD + MD(s) 16 (5/24)
 Multiple LDs 13 (2/24)
Timing in hours of the serum lab draw following last PHT dose, Mean (Min/Max)
 LD + MD(s) 5 (2/13)
 Multiple LDs 7 (2/21)
Diagnoses on admission
 Known seizure disorder/Epilepsy 158
 Altered mental status 42
 Traumatic brain injury/Trauma 35
 Intracerebral hemorrhage 34
 Subdural hematoma 24
 Brain mass (primary or secondary) 24
 Acute stroke 19
 Subarachnoid hemorrhage 15
 Infectious meningitis/Encephalitis 8
 Cardiac arrest 5
 Epidural hematoma 4
 Other medical conditions (*) 93

(*) Other conditions registered as the primary diagnosis included urinary tract infections, asphyxiation, long bone fractures, pseudo-seizure, gunshot to the abdomen, etc. See Supplemental data for further details and the list of secondary and tertiary diagnoses.